Home Cart Sign in  
Chemical Structure| 906669-07-6 Chemical Structure| 906669-07-6

Structure of KPLH1130
CAS No.: 906669-07-6

Chemical Structure| 906669-07-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

KPLH1130 is a specific pyruvate dehydrogenase kinase (PDK) inhibitor that effectively blocks macrophage polarization and reduces pro-inflammatory responses. This compound shows potential to improve glucose tolerance in high-fat diet mouse models, making it suitable for studying metabolic and inflammation-related diseases.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of KPLH1130

CAS No. :906669-07-6
Formula : C15H13N3O3
M.W : 283.28
SMILES Code : O=C1NN=C(N1C2=CC=C(C)C=C2)C3=C(O)C=C(O)C=C3
MDL No. :MFCD32067959

Safety of KPLH1130

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Description
KPLH1130 is a selective inhibitor of pyruvate dehydrogenase kinase (PDK), which inhibits macrophage polarization and reduces proinflammatory reactions. Furthermore, KPLH1130 enhances glucose tolerance in mice fed with a high-fat diet (HFD)[1].

In Vitro:

Cell Line
Concentration Treated Time Description References
PMs 10 µM 12 h To evaluate the effect of KPLH1130 on M1 polarization of macrophages. PMC6514528
BMDMs 10 µM 12 h To evaluate the effect of KPLH1130 on M1 polarization of macrophages. PMC6514528
HD11 cells 7 μM 24 h Inhibited DEHP-induced M1 polarization and promoted M2 polarization in HD11 cells PMC11665341
hUC-MSCs 10 μM 1 h Inhibits pyruvate dehydrogenase kinase activity, affecting the immunosuppressive function of hUC-MSCs PMC9463493

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice High-fat diet-induced obesity model 70 mg/kg 4 weeks Evaluate the effect of KPLH1130 on high-fat diet-induced insulin resistance, results showed that KPLH1130 significantly improved glucose tolerance and insulin sensitivity PMC6514528

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.53mL

0.71mL

0.35mL

17.65mL

3.53mL

1.77mL

35.30mL

7.06mL

3.53mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories